Evidence map›Paper›PMID 29862213›Full record

ArticleAdvanced biomedical research2018

Synthesis and

Maryam Mohajeri, Lotfollah Saghaei, Mustafa Ghanadian, Sedighe Saberi, Nader Pestechian, Ehsan Ostadhusseini

Abstract read
In one paragraph

Article in Advanced biomedical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Direct Assembly of Metal-Phenolic Network Nanoparticles for Biomedical Applications.Angewandte Chemie (International ed. in English) · 2023
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam MohajeriDepartment of Medicinal Chemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Lotfollah SaghaeiDepartment of Medicinal Chemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mustafa GhanadianDepartment of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Sedighe SaberiDepartment of Medical Mycoparasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nader PestechianDepartment of Medical Mycoparasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Ehsan OstadhusseiniDepartment of Medicinal Chemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundToday, leishmaniasis is a widespread, infectious parasitic disease caused by MATERIALS AND

methodsIn this study, during a regioselective method, quercetin derivatives were synthesized. The structures of synthesized compounds were confirmed by mass, IR,

resultsIn this study, during a regioselective method, two 7-O-quercetin derivatives (5 and 6), and three quercetin acetate derivatives (2, 3, and 4) were synthesized. In detail, the IC

conclusionsThe present study showed an effective antileishmanial activity of quercetin semisynthetic compounds (1-6) against

Indexed as

Leishmanicidal activityquercetin derivativesregioselective synthesis

Identifiers

PMID29862213
PMCPMC5952540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.